Company Name or Ticker Symbol
Search for other Categories

Exact Sciences Corp  (EXAS)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories

EXAS's Revenue Year on Year Growth by Quarter and Year

Exact Sciences's Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
EXAS Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December 99.38 14.42 1.50 1.04
III Quarter September 28.12 12.63 - 1.04
II Quarter June 21.19 8.12 - 1.04
I Quarter March 14.84 4.27 0.29 1.04
FY   163.53 39.44 1.79 4.16

Financial Statements
Exact Sciences's forth quarter 2016 Revenue $ 99.38 millions EXAS's Income Statement
Exact Sciences's forth quarter 2015 Revenue $ 14.42 millions Quarterly EXAS's Income Statement
EXAS's Growth by Division See EXAS's Growth by Segment

EXAS Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December 589.15 % 861.33 % 44.23 % 0 %
III Quarter September 122.64 % - - 0 %
II Quarter June 160.96 % - - 0 %
I Quarter March 247.54 % 1372.41 % -72.12 % -
FY   314.62 % 2103.35 % -56.97 % -

EXAS Revenue Growth Comment
Exact Sciences Corp achieved in the forth quarter, above Company average Revenue surge of 589.15% year on year, to $ 99.38 millions.

Looking into forth quarter results within Medical Laboratories industry 2 other companies have achieved higher Revenue growth. While Exact Sciences Corp' s Revenue doubling of 589.15% ranks overall at the positon no. 53 in the forth quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #15
S&P 500 #53
Revenue Y/Y Growth Statistics
High Average Low
1351.02 % 264.61 % -100 %
(Mar 31 2015)   (Sep 30 2014)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EXAS's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for EXAS's Competitors
Revenue Growth for Exact Sciences's Suppliers
Revenue Growth for EXAS's Customers

You may also want to know
EXAS's Annual Growth Rates EXAS's Profitability Ratios EXAS's Asset Turnover Ratio EXAS's Dividend Growth
EXAS's Roe EXAS's Valuation Ratios EXAS's Financial Strength Ratios EXAS's Dividend Payout Ratio
EXAS's Roa EXAS's Inventory Turnover Ratio EXAS's Growth Rates EXAS's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Dec 31 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2016
Arena Pharmaceuticals Inc  1,001.46 %$ 1,001.458 millions
Innovus Pharmaceuticals, Inc.  863.00 %$ 863.000 millions
Dynavax Technologies Corp  814.74 %$ 814.745 millions
Exact Sciences Corp  589.15 %$ 589.154 millions
Sophiris Bio Inc.  550.00 %$ 550.000 millions
Juno Therapeutics, Inc.  409.47 %$ 409.465 millions
Eagle Pharmaceuticals, Inc.  346.31 %$ 346.315 millions
Sarepta Therapeutics, Inc.  332.64 %$ 332.642 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
SFS's Profile
Stock Price
SFS's Financials
SFS's Expectations
Business Description
Charts & Quotes
SFS's News
SFS's Competitors
Customers & Markets
Economic Indicators
SFS's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com